Moderna (MRNA) News Today $26.20 +1.70 (+6.94%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$26.32 +0.12 (+0.46%) As of 04/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Shelton Capital Management Has $485,000 Holdings in Moderna, Inc. (NASDAQ:MRNA)Shelton Capital Management cut its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 79.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,672 shares of the company's stock after selling 46,312 shares duriApril 12 at 6:15 AM | marketbeat.comMorgan Stanley Cuts Moderna (NASDAQ:MRNA) Price Target to $32.00April 12 at 2:35 AM | americanbankingnews.comWhat are mRNA vaccines, and how do they work?April 11 at 5:13 PM | msn.comMorgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock PriceMorgan Stanley reduced their target price on Moderna from $39.00 to $32.00 and set an "equal weight" rating on the stock in a report on Wednesday.April 11 at 10:28 AM | marketbeat.comAviva PLC Has $8.24 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Aviva PLC reduced its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 198,173 shares of the company's stock after selling 51,303 shares duringApril 11 at 5:17 AM | marketbeat.comResona Asset Management Co. Ltd. Acquires New Stake in Moderna, Inc. (NASDAQ:MRNA)Resona Asset Management Co. Ltd. bought a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 94,753 shares of the company's stock, valued at approxApril 11 at 5:07 AM | marketbeat.comFmr LLC Has $776.08 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Fmr LLC boosted its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 18,664,634 shares of the company's stock after buying an additional 1,282,469 shares during the period. Fmr LLC oApril 10 at 6:13 AM | marketbeat.comModerna price target lowered to $32 from $39 at Morgan StanleyApril 9 at 8:23 PM | markets.businessinsider.comModerna (MRNA) Receives a Hold from Morgan StanleyApril 9 at 8:23 PM | markets.businessinsider.comModerna (NASDAQ:MRNA) Hits New 12-Month Low - Here's What HappenedModerna (NASDAQ:MRNA) Reaches New 12-Month Low - What's Next?April 9 at 10:56 AM | marketbeat.comAster Capital Management DIFC Ltd Acquires New Shares in Moderna, Inc. (NASDAQ:MRNA)Aster Capital Management DIFC Ltd bought a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 11,987 shares of the company's stock, valuedApril 9 at 6:15 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Sit Investment Associates Inc.Sit Investment Associates Inc. decreased its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 59.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,409 shares of the company's stock after selling 10,675 sharesApril 9 at 5:39 AM | marketbeat.comWhy Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022April 8, 2025 | fool.comWhy Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022April 8, 2025 | fool.comIs Moderna, Inc. (MRNA) the Best Long Term Growth Stock to Buy According to Billionaires?April 8, 2025 | msn.comAnti-vaccine sentiment may derail vaccines already awaiting FDA approval, experts fearApril 8, 2025 | msn.comTitleist Asset Management LLC Sells 18,528 Shares of Moderna, Inc. (NASDAQ:MRNA)Titleist Asset Management LLC cut its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 37.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,522 shares of the company's stock after selling 18,528 shares during the quarteApril 8, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Stock Holdings Increased by Himension Capital Singapore PTE. LTD.Himension Capital Singapore PTE. LTD. boosted its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 201.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,598 shares of the company's stock after purchasing an additiApril 8, 2025 | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Takes Position in Moderna, Inc. (NASDAQ:MRNA)Grantham Mayo Van Otterloo & Co. LLC bought a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 547,812 shares of the companApril 8, 2025 | marketbeat.com87,970 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by ExodusPoint Capital Management LPExodusPoint Capital Management LP acquired a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 87,970 shares of the company's stock, valued at appApril 8, 2025 | marketbeat.comNational Bank of Canada FI Sells 66,191 Shares of Moderna, Inc. (NASDAQ:MRNA)National Bank of Canada FI decreased its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 28.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 169,075 shares of the company's stock afterApril 8, 2025 | marketbeat.comSchroder Investment Management Group Has $1.26 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA)Schroder Investment Management Group lessened its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 76.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 32,104 shares of the company's stock after selling 103,4April 8, 2025 | marketbeat.comGeode Capital Management LLC Raises Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Geode Capital Management LLC raised its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,241,354 shares of the company's stock after buying an additionaApril 7, 2025 | marketbeat.comMotley Fool Asset Management LLC Has $236,000 Stake in Moderna, Inc. (NASDAQ:MRNA)Motley Fool Asset Management LLC reduced its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 63.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,668 shares of the company's stoApril 6, 2025 | marketbeat.comCinctive Capital Management LP Invests $659,000 in Moderna, Inc. (NASDAQ:MRNA)Cinctive Capital Management LP acquired a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 15,842 shares of the company's stock, valued at approximateApril 6, 2025 | marketbeat.comCalifornia Public Employees Retirement System Has $16.29 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA)California Public Employees Retirement System lessened its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 55.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 391,759 shares of the company's stock aftApril 6, 2025 | marketbeat.comJim Cramer Calls Moderna (MRNA) ‘Problematic’April 5, 2025 | insidermonkey.comWellington Management Group LLP Sells 1,309,593 Shares of Moderna, Inc. (NASDAQ:MRNA)Wellington Management Group LLP lessened its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 25.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,915,092 shares of the company's stock after selling 1,309,593 sharesApril 4, 2025 | marketbeat.comAllstate Corp Takes Position in Moderna, Inc. (NASDAQ:MRNA)Allstate Corp bought a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 9,514 shares of the company's stock, valued at approximately $396,000. A number ofApril 4, 2025 | marketbeat.comS. Korean team uncovers how mRNA vaccines work at cellular levelApril 4, 2025 | msn.comModerna (MRNA) Gets a Hold from BernsteinApril 3, 2025 | markets.businessinsider.comBetter Beaten-Down Stock to Buy: Pfizer Vs. ModernaApril 3, 2025 | fool.comNomura Asset Management Co. Ltd. Has $4.17 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Nomura Asset Management Co. Ltd. trimmed its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 12.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,180 shares of the companyApril 3, 2025 | marketbeat.comFDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy?April 3, 2025 | fool.comLPL Financial LLC Acquires 269,682 Shares of Moderna, Inc. (NASDAQ:MRNA)LPL Financial LLC increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 274.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 367,878 shares of the compApril 3, 2025 | marketbeat.comIs Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?April 3, 2025 | finance.yahoo.com4MRNA : Moderna Options Trading: A Deep Dive into Market SentimentApril 2, 2025 | benzinga.comEdmond DE Rothschild Holding S.A. Cuts Stake in Moderna, Inc. (NASDAQ:MRNA)Edmond DE Rothschild Holding S.A. lowered its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 22.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 74,083 shares of the company's stock after selling 21,888 shares duApril 2, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by AIA Group LtdAIA Group Ltd increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 192.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,640 shares of the company's stock after buying an addApril 2, 2025 | marketbeat.com3,940,194 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Norges BankNorges Bank acquired a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 3,940,194 shares of the company's stock, valued at approximately $163,833,000. Norges Bank owned approximately 1.02% of Moderna aApril 2, 2025 | marketbeat.comModerna (NASDAQ:MRNA) Sets New 52-Week Low - What's Next?Moderna (NASDAQ:MRNA) Hits New 12-Month Low - Time to Sell?April 2, 2025 | marketbeat.comIs Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?April 2, 2025 | msn.comTrump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocksApril 1, 2025 | cnbc.comModerna (NASDAQ:MRNA) Shares Gap Down - What's Next?Moderna (NASDAQ:MRNA) Shares Gap Down - Here's WhyApril 1, 2025 | marketbeat.comUniSuper Management Pty Ltd Purchases 20,862 Shares of Moderna, Inc. (NASDAQ:MRNA)UniSuper Management Pty Ltd lifted its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 69.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,953 shares of the company's stock afteApril 1, 2025 | marketbeat.comCorebridge Financial Inc. Sells 28,775 Shares of Moderna, Inc. (NASDAQ:MRNA)Corebridge Financial Inc. lowered its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 24.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,706 shares of the company's stoApril 1, 2025 | marketbeat.comWatch These Moderna Price Levels as Stock Sinks to 5-Year LowApril 1, 2025 | msn.comModerna put volume heavy and directionally bearishMarch 31, 2025 | markets.businessinsider.comFDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)March 31, 2025 | seekingalpha.comModerna (MRNA) Stock Trades Down, Here Is WhyMarch 31, 2025 | msn.com Remove Ads Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.980.95▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼2825▲MRNA Articles Average Week Remove Ads Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Intra-Cellular Therapies News Summit Therapeutics News Genmab A/S News Dr. Reddy's Laboratories News Viatris News Qiagen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredDOGE’s 690% winning stockElon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRNA Stock Free MRNA Stock Alerts